MedWatch

CEO: Now the Danes need a new small pox vaccine

Bavarian Nordic is ready to go directly for emergency physician throughout the EU with the company's small pox vaccine – including home country Denmark, where a stockpiled, out-dated vaccine is “brimming with serious side effects”.

Foto: PR, Bavarian Nordic

The effort to market Bavarian Nordic’s small pox vaccine in the EU countries can now truly commence.

Last week’s announcement from the European advisory committee, CHMP, concerning a positive recommendation of the vaccine Imvanex is to be used as a impetus, according to company CEO Anders Hedegaard.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier